Relationship between Mutations of the Epidermal Growth Factor Receptor Gene and Drug-Resistance to Gefitinib in Human Lung Cancer in vitro
Background and objective To explore cell lines' difference of drug-resistance to gefitinib and the underlying mechanism. Methods Human lung cancer cell lines of PC9, PC9/AB2, PC9/AB11, PC9/BB4 were treated in vitro , exons 18-21 of EGFR gene were sequenced and EGFR gene mRNA levels were measure...
Main Authors: | Wei WEI, Yu FAN, Hongyu LIU, Zhihao WU, Haisu WAN, Zhiqin YAN, Ke XU, Qinghua ZHOU |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2009-01-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://www.lungca.org/index.php?journal=01&page=article&op=view&path%5B%5D=10.3779%2Fj.issn.1009-3419.2009.01.004&path%5B%5D=197 |
Similar Items
-
Efficacy of Gefitinib for Young Patients with Unknown EGFR Gene Mutation
in Advanced Lung Adenocarcinoma
by: Yutao LIU, et al.
Published: (2014-05-01) -
A Randomized Clinical Study of Gefitinib and Pemetrexed as Second Line Therapy
for Advanced Non-squamous Non-small Cell Lung Cancer
by: Hongyu DAI, et al.
Published: (2013-08-01) -
Effects of paclitaxel and gefitinib on the proliferation and cell cycle of human lung adenocarcinoma cell SPC-A1
by: Gang JIA, et al.
Published: (2008-06-01) -
Modern vector in treatment of patients with lung cancer: tyrosine kinase inhibitors in epidermal growth factor receptor mutations (literature review)
by: O.M. Smorodska, et al.
Published: (2021-06-01) -
Gefitinib for Non-small Cell Lung Cancer: A meta Analysis
by: Jiwu GUO, et al.
Published: (2011-04-01)